QNRX News - Candlesense

Quoin Pharmaceuticals’ NETHERTON NOW Campaign Surpasses One Million Video Views, Amplifying Global Awareness of Netherton Syndrome

ASHBURN, Va., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (“Quoin” or the “Company”), a clinical-stage specialty pharmaceutical company focused on rare and orphan ...

Awareness

about 2 hours ago

Quoin Pharmaceuticals Appoints New Chief Financial Officer to Support Commercialization Strategy

ASHBURN, Va., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (“Quoin” or the “Company”), a late clinical stage specialty pharmaceutical company focused on rare and or...

Will the appointment signal upcoming financing activities (e.g., equity raises, debt issuance) or partnerships that could impact the company's balance sheet and share dilution? What are the expected short‑term and long‑term effects of this leadership change on QNRX's stock liquidity and valuation? How will the new CFO's experience influence Quoin Pharmaceuticals' financial strategy and capital allocation for QRX003 commercialization?

Management

3 days ago